Story Navigation
-
DiscoveryBiomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchClinical ScienceCancer Research InstituteResearchers aim to beat trick play by tumors with drug comboDiscovery
-
DiscoveryEye CareFuture of HealthcareInnovationMedical InnovationsA fresh look at fighting glaucoma
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
Discovery -
DiscoveryDrug DiscoveryFuture of HealthcareInnovationLiving With DiseaseNovartis Institutes for BioMedical ResearchCan we unlock the body's ability to regenerate lost hearing?
When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.
Discovery -
DiscoveryFuture of HealthcareInnovationBiological battle of the bulge
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesClinical ResearchCareersBiomedical JobsGene TestingGenetic DiseaseNovartis researches SMA’s genetic roots
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchNovartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchMutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchTargeted TherapyCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: LEE011 – a popular combination partnerDiscovery
-
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: ABL001 – hitting one target twiceDiscovery
-
DiscoveryNovartis Institutes for BioMedical ResearchNovartis antibody increases muscle growth in mice and human cell cultures
An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.
Discovery -
DiscoveryChildren's HealthGene SequencingInnovationNeurodegenerative DiseaseRare DiseasesTackling a rare disease: Working toward a treatment for SMA
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- › Next page